Bulletin
Investor Alert

May 26, 2020, 11:06 a.m. EDT

High-Dividend Paying Healthcare Stocks: $CAPR $CEMI $VBIV

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Capricor Therapeutics Inc. (CAPR)
  • X
    Chembio Diagnostics Inc. (CEMI)
  • X
    VBI Vaccines Inc. (VBIV)

or Cancel Already have a watchlist? Log In

May 26, 2020 (The Market Signal via Comtex) -- Sector Reports was created as a platform to help investors find the best free Stock Reports on stocks they own. If you are a shareholder or looking for stocks to buy /zigman2/quotes/200227770/composite CAPR -17.34% , /zigman2/quotes/200199230/composite CEMI +0.92% or /zigman2/quotes/201705917/composite VBIV +0.83% then we strongly urge you to join our community by signing up with the link below and getting a completely free research report on each company today.

http://www.sectorreports.com.au/Free-Report/NOW

(Click link above or copy, paste and hit enter in your browser for your report)

Capricor Raised Net Proceeds of Approximately $12.8 Million in Offering Program in Q1 2020

https://www.sectorreports.com.au/landing-page/?symbol=CAPR

(Click link above or copy, paste and hit enter in your browser for your report)

Capricor Therapeutics Inc ( NASDAQ: CAPR ) closed at $5.39 after rising by 1.89% yesterday. On May 15, the company had reported its financial result for the first quarter of 2020 for period ending March 31, 2020. Net loss of approximately $2.1 million, or $0.30 per share, for Q1 2020 was reported, relative to net loss of approximately $2.5 million, or $0.75 per share, for Q1 2019.

The Company ended the quarter with cash, cash equivalents and marketable securities of approximately $13.2 million, compared with approximately $9.9 million in its previous quarter ending on December 31, 2019.

In Q12020, Capricor generated net proceeds of approximately $4.5 million as it completed warrant inducement. From January 1 through May 13, Capricor raised net proceeds of approximately $12.8 million under its at-the-market offering program at an average price of approximately $7.34 per share.

Chembio Reports Its First Quarter 2020 Financial Results

https://www.sectorreports.com.au/landing-page/?symbol=CEMI

(Click link above or copy, paste and hit enter in your browser for your report)

Chembio Diagnostics Inc /zigman2/quotes/200199230/composite CEMI +0.92% closed at $10.87 after rising by 6.57% yesterday. The leading point-of-care diagnostics company that focuses primarily on infectious diseases reported its Q1 2020 financial results earlier this month.

Total revenue for Q1 2020 was $6.9 million, declining 20% in comparison with Q1 2019. Net product sales for Q1 2020 came out at $5.7 million, indicating a decrease of 14% in comparison with corresponding period in the previous year. In Q1 2020, license and royalty revenue with R&D and grant revenue totalled $1.1 million, declining 40% as against Q1 2019.

Company incurred lesser amount on research and development in Q1 2020. The expenses decreased by $0.3 million, or 12%, for the reported quarter. Net loss for Q1 2020 was $5.0 million, or $0.29 per diluted share, relative to a net loss of $2.8 million, or $0.16 per diluted share, for Q12019.

The company ended Q1 2020 with cash and cash equivalents as of March 31, 2020 at $11.2 million.

VBI Vaccines Rakes in $0.42 Million Revenue in Q1 2020 with Sci-B-Vac(R) Sales in Europe

https://www.sectorreports.com.au/landing-page/?symbol=VBIV

/zigman2/quotes/200227770/composite
US : U.S.: Nasdaq
$ 6.53
-1.37 -17.34%
Volume: 5.07M
Aug. 7, 2020 4:00p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$108.82 million
Rev. per Employee
$29,603
loading...
/zigman2/quotes/200199230/composite
US : U.S.: Nasdaq
$ 5.49
+0.05 +0.92%
Volume: 5.01M
Aug. 7, 2020 4:00p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$110.73 million
Rev. per Employee
$113,252
loading...
/zigman2/quotes/201705917/composite
US : U.S.: Nasdaq
$ 4.25
+0.04 +0.83%
Volume: 5.85M
Aug. 7, 2020 4:00p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$981.44 million
Rev. per Employee
$29,955
loading...
/zigman2/quotes/200199230/composite
US : U.S.: Nasdaq
$ 5.49
+0.05 +0.92%
Volume: 5.01M
Aug. 7, 2020 4:00p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$110.73 million
Rev. per Employee
$113,252
loading...
1 2
This Story has 0 Comments
Be the first to comment

Story Conversation

Commenting FAQs »
Link to MarketWatch's Slice.